PLPL Company Profile and Key Details

Average 10-day trading volume of 14.44 million shares is significantly above the 3-month average of 8.09 million, indicating heightened recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

The stock is currently trading near its 52-week high $0.00 and $0.00. With a market capitalization of about $4.49 million, Plandaí Biotechnology, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~9.73). Key stats such as the average daily volume over the past year has been around 2.11 million shares, trading with heavier-than-usual volume. Headquartered in Taipei, TP, Plandaí Biotechnology, Inc. operates in the Financial Services sector and the Shell Companies industry. Led by CEO Yi-Kuan Lin, the company employs approximately 180 people and listed since February 02, 1995. Plandaí Biotechnology, Inc. does not have significant operations.

Valuation shows Plandaí Biotechnology, Inc. trading at a premium to the broader market with a P/E of -74.65.

Our AI price prediction model suggests that Plandaí Biotechnology, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Plandaí Biotechnology, Inc. trades at a P/E ratio of -74.65, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 The P/FCF stands at 0.0, also above market averages.